FDA’s Draft Guidance on eRecords Could Have Unintended Consequences


    loading  Checking for direct PDF access through Ovid

Abstract

The FDA’s draft guidance on the use of electronic records and electronic signatures encourages systems to improve quality and efficiency, and expands the use of a risk-based approach in validating and establishing audit trails for electronic systems. But it’s the validation part of the proposed guidance that could introduce a new problem.

    loading  Loading Related Articles